Envoy Medical wins new Canadian, Hong Kong patents, lifts global total to 97

• Envoy Medical reported two newly granted international patents, lifting its global total to 97 granted patents as of Sept. 22, 2026.
• The additions include one Canadian patent covering integrated implantable cochlear components, lead characterization, and conductor testing within the system.
• A Hong Kong patent covers methods to compensate for variability in a middle-ear sensor, including signal processing to normalize sensor output.
• Portfolio now includes 40 granted U.S. patents, 57 granted foreign patents, and 35 pending applications, supporting its fully implanted hearing platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609220830NEWSFILECNPR____20260922_315331_1) on September 22, 2026, and is solely responsible for the information contained therein.